We found that ixazomib could overcome dox-induced chemoresistance by stabilizing IκBα expression levels and inactivating NF-κB in NB cell lines, including the chemoresistance LA-N-6 cell line. The gene discussed is NFKB1; the disease is neuroblastoma.